{
  "html": "<table border=\"1px\" style=\"width: 100%;\"> <tbody><tr><td>&nbsp;</td>\n\t\t\t\t\t<th>PC Number</th>\n\t\t\t\t\t<th>Date</th>\n\t\t\t\t\t<th>Chapter</th>\n\t\t\t\t\t<th>Bill</th>\n\t\t\t\t\t<th>Dept</th></tr><tr><td style=\"min-width: 120px;\">&nbsp;</td><td>2021-1029</td><td>2021-12-17</td><td></td><td></td><td>,&nbsp; ,&nbsp; ,&nbsp; HC,&nbsp; ,&nbsp; </td></tr><tr><td>Act</td><td colspan=\"5\">Food and Drugs Act<br>Controlled Drugs and Substances Act</td></tr><tr><td>Subject</td><td colspan=\"5\">Regulations Amending Certain Regulations Relating to Restricted Drugs (Special Access Program)</td></tr><tr><td>Precis</td><td colspan=\"5\" id=\"precis\">Regulations amending CERTAIN REGULATIONS RELATING TO RESTRICTED DRUGS (SPECIAL ACCESS PROGRAM) in order to (1) repeal the provisions in Part C of the Food and Drug Regulations that prohibit the authorization of the sale or importation of a restricted drug for the purposes of the Special Access Program; and (2) allow Health Canada the discretion to authorize the sale of restricted drugs for the purposes of emergency treatment through the Special Access Program, provided the application submitted by the practitioner meets all applicable requirements.</td></tr><tr><td>Registration</td><td colspan=\"5\" id=\"registration\"><strong>Registration: </strong>SOR/ 2021-0271  <strong>Publication Date:</strong> 2022-01-05</td></tr><tr><td>Attachments</td><td colspan=\"5\"><a href=\"attachment.php?attach=41411&amp;lang=en\">Attachment</a></td></tr></tbody></table>",
  "pcNumber": "2021-1029",
  "htmlHash": "ef53bdd2457be33b3b6bf44123073769",
  "attachments": [
    "41411"
  ],
  "date": "2021-12-17",
  "chapter": "",
  "bill": "",
  "department": ", , , HC, , ",
  "act": "Food and Drugs ActControlled Drugs and Substances Act",
  "subject": "Regulations Amending Certain Regulations Relating to Restricted Drugs (Special Access Program)",
  "precis": "Regulations amending CERTAIN REGULATIONS RELATING TO RESTRICTED DRUGS (SPECIAL ACCESS PROGRAM) in order to (1) repeal the provisions in Part C of the Food and Drug Regulations that prohibit the authorization of the sale or importation of a restricted drug for the purposes of the Special Access Program; and (2) allow Health Canada the discretion to authorize the sale of restricted drugs for the purposes of emergency treatment through the Special Access Program, provided the application submitted by the practitioner meets all applicable requirements.",
  "registration": "Registration: SOR/ 2021-0271  Publication Date: 2022-01-05",
  "registration_type": "SOR",
  "registration_id": "2021-0271",
  "registration_publication_date": "2022-01-05"
}